Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_001904.4(CTNNB1):c.119C>A(p.Thr40Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CTNNB1. . Gene score misZ 3.846 (greater than the threshold 3.09). Trascript score misZ 5.712 (greater than threshold 3.09). GenCC has associacion of gene with severe intellectual disability-progressive spastic diplegia syndrome, exudative vitreoretinopathy, exudative vitreoretinopathy 7.
BP4
Computational evidence support a benign effect (MetaRNN=0.23783249).
Loss of glycosylation at T40 (P = 0.0071);.;Loss of glycosylation at T40 (P = 0.0071);.;Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);.;Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);.;.;Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);.;.;.;.;Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);.;Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);.;Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);.;Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);Loss of glycosylation at T40 (P = 0.0071);